A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma
Clinical trial NCT01609010 · COMPLETED
Trial details
- NCT number
- NCT01609010
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.